Bristol-Myers Squibb Company, Pfizer Inc. Drug Cuts Stroke Risk By Half Vs Aspirin
STOCKHOLM, Aug 31 (Reuters) - An experimental drug from Bristol-Myers Squibb (BMY.N) and Pfizer (PFE.N) reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday.